Metabolic and Glycemic Effects of Orforglipron, a GLP‐1 Receptor Agonist, in Adults With or Without Diabetes: A Network Meta‐Analysis of Randomised Clinical Trials (Endocrinology, Diabetes & Metabolism, 2026)